Status:

TERMINATED

Cardiovascular Consequences After COVID-19

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Cardiovascular Consequences After an Episode of COVID 19

Eligibility:

All Genders

18+ years

Brief Summary

The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coron...

Eligibility Criteria

Inclusion

  • • All adults affiliated to social security attending the post-Covid follow-up consultation, having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.

Exclusion

  • Age \<18 years old
  • Major under guardianship or curatorship
  • Absence of non-opposition

Key Trial Info

Start Date :

June 23 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04452630

Start Date

June 23 2020

End Date

February 1 2023

Last Update

November 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hôpitaux de Marseille

Marseille, France, 13005